Last reviewed · How we verify

NCT06780956

Simplified vs Conventional Drilling Protocol for Implant Placment

Completed Phase 3 Last updated 17 January 2025
What this trial tests

Phase 3 trial testing Conventional in MBL in 46 participants. Completed in 1 March 2024.

Timeline
1 December 2020
Primary endpoint
1 July 2023
1 March 2024

Quick facts

Lead sponsorUniversidad Católica San Antonio de Murcia
PhasePhase 3
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment46
Start date1 December 2020
Primary completion1 July 2023
Estimated completion1 March 2024
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Universidad Católica San Antonio de Murcia

Who can join

Eligibility, any sex, with MBL or Bone Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Despite the growing interest in these alternative drilling protocols, there is a lack of robust clinical evidence evaluating their long-term effects on MBL. The aim of the present study was therefore, to evaluate the effect of implant site preparation technique (conventional drilling versus simplfied) on change in the marginal bone level and insertion torque.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Bone Remodeling and Marginal Bone Loss of Simplified Versus Conventional Drilling: A Randomized Clinical Trial.
    Ruiz García A, Lijnev A, Soleymani F, Elango J, et al · · 2025 · PMID 40001697 · DOI 10.3390/bioengineering12020178

Verify or expand the search:

Other trials of Conventional

Trials testing the same drug.

Other Universidad Católica San Antonio de Murcia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06780956.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing